GNAS mutational status could not provide a complete explanation of the clinical characteristics of acromegaly; however, proteomics analysis showed that GNAS-MT influenced the expression of many proteins, including those involved in the GPCR pathway. The gene discussed is GNAS; the disease is acromegaly.